Automation
Architecture review before implementation
Implementation scope and rollout planning
Clear next-step recommendation
This page details a production-grade automation that extracts patient data from the EHR, transforms it to match trial-specific case report forms, and submits it to the Electronic Data Capture system via API, eliminating manual double-data entry for clinical research sites.
Manual transfer of patient data from EHRs like Epic or Cerner to EDC systems like Medidata Rave or Oracle Clinical is a costly, error-prone bottleneck. This custom workflow automates the extraction, mapping, and submission process, reducing site burden by 60-80% and cutting query rates by improving data accuracy. The business case is clear: faster database locks, lower trial costs, and improved data quality for regulatory submission, directly impacting study timelines and operational margins.
Implementation requires building an agentic layer, often with LangGraph or a custom orchestrator, that listens to EHR HL7/FHIR feeds. It applies sponsor-specific mapping rules, handles data type transformations, and manages API submission with retry logic. Critical for production is embedding robust validation against the clinical trial protocol, a human-in-the-loop queue for unmapped fields or discrepancies, and a full audit trail for 21 CFR Part 11 compliance. The architecture must integrate with the site's EDC and EHR, requiring careful scoping of API capabilities and data governance controls.
Transforming clinical trial data management from a manual, error-prone cost center into a high-velocity, quality-controlled strategic asset that accelerates study timelines and improves data integrity.
Automates the extraction of patient data from the EHR (e.g., Epic, Cerner) and its direct transformation and submission into the Electronic Data Capture (EDC) system via API. This removes the primary site burden, where coordinators spend 15-25 hours per patient manually transcribing data, which is a leading cause of protocol deviations and query volume.
By reducing site coordinator workload per patient, sites can enroll more subjects without adding staff. Cleaner, automated data submission reduces time spent on query resolution and monitoring visits, directly shortening the data lock cycle. This turns data management from a timeline bottleneck into an accelerator for trial completion.
The workflow enforces consistent mapping logic (e.g., LOINC to CDISC) and applies validation rules at the point of extraction, catching discrepancies before submission. A complete, immutable audit trail from EHR source to EDC submission is automatically generated, strengthening defensibility for FDA/EMA audits and reducing compliance risk.
Directly lowers the cost per CRF page by automating the most labor-intensive step in clinical operations. Reduces coordinator and CRA burnout from repetitive administrative tasks, allowing staff to focus on higher-value patient care and protocol adherence. The ROI is measured in FTEs saved per study and reduced monitoring costs.
Creates a near-real-time pipeline from patient visit to EDC, enabling sponsors and CROs to monitor patient safety and study progress with minimal latency. This supports a shift to risk-based monitoring (RBM) by providing clean, timely data for centralized statistical monitoring, further reducing on-site visit frequency and cost.
The custom workflow is not a one-time fix but a production-grade orchestration layer (using tools like LangGraph) that can be templatized and re-deployed across studies and therapeutic areas. It creates a strategic capability to launch new trials faster, with lower incremental cost, turning the data function into a competitive advantage.
This architecture details the custom multi-agent system that orchestrates the secure, compliant transfer of patient data from the EHR to the Electronic Data Capture system, eliminating manual double-data entry for clinical trials.
The workflow's business value is direct: it automates a high-volume, error-prone manual task, reducing site burden by 60-80% and accelerating trial data lock. Savings come from eliminating FTEs dedicated to manual transcription and from reducing costly query resolution cycles caused by entry errors. The architecture is event-driven, triggered by a signed visit in the EHR or a scheduled EDC transfer, initiating a secure orchestration layer that manages the entire data flow, validation, and submission lifecycle.
Implementation requires deep integration with EHRs like Epic or Cerner via FHIR/HL7 and EDC systems like Medidata Rave or Veeva via REST APIs. The Orchestrator Agent, built on a framework like LangGraph, sequences specialist agents for extraction, mapping logic, and validation against clinical trial protocols. Critical controls include an immutable audit trail for regulatory compliance, a human-in-the-loop review queue for unmapped fields or validation failures, and reconciliation logic to handle data drift between source and target systems post-submission.
A custom agentic workflow for clinical trials that automates the extraction, transformation, and submission of patient data from the EHR to the Electronic Data Capture system, eliminating manual double-data entry.
This agent connects to the EHR (e.g., Epic, Cerner) via FHIR/HL7 APIs to extract discrete patient data points. It executes a pre-configured field mapping, translating local EHR codes (LOINC, SNOMED) to the target EDC's case report form (CRF) variables. The agent handles missing data logic and logs all source data with timestamps for the audit trail.
A rules-based engine applies trial-specific derivations and data transformations. It calculates values (e.g., BMI from height/weight), applies unit conversions, and formats dates per the EDC's protocol. Complex logic, such as determining adverse event severity from lab values, is executed here before submission, ensuring data quality and reducing manual rework.
This agent manages the transactional interface with the EDC system (e.g., Medidata Rave, Veeva). It submits transformed data via REST APIs, handles response codes (success, rejection), and manages automatic retries for transient failures. It also performs reconciliation by comparing EHR-source data with the confirmed EDC record, flagging any mismatches for review.
A centralized queue routes exceptions for clinical data manager (CDM) review. Exceptions include unmapped fields, transformation failures, data quality flags (e.g., out-of-range values), and reconciliation mismatches. The interface presents fused source data, transformation logic, and allows the CDM to approve, edit, or reject the transfer, with all actions logged.
A immutable log captures the complete data lineage for regulatory compliance (21 CFR Part 11, GCP). It records every action: data extraction timestamp, raw values, transformation logic applied, submission attempts, reviewer decisions, and final reconciled state. This log is essential for source data verification (SDV) and provides a defensible record for trial monitors and auditors.
The central workflow orchestrator, built on a framework like LangGraph, defines the state machine and sequence of agentic steps. It manages retry logic, parallel processing for multiple patients, and monitors system health (API latency, error rates). It provides the operational dashboard for throughput metrics and alerts site staff to systemic issues requiring intervention.
A phased implementation strategy for automating clinical trial data transfer, designed to mitigate risk, ensure regulatory compliance, and deliver incremental operational value.
Phase 1 establishes the core extraction and validation pipeline. We begin by building a secure, containerized agent that connects to the EHR's FHIR API, focusing on a single, high-value data domain like patient demographics or lab results. This agent maps source fields to the EDC's CDISC ODM structure, performs basic validation, and writes to a staging database. The initial deliverable is a functioning, auditable data flow for one study site, providing immediate validation of the technical architecture and data quality before scaling complexity.
Phase 2 expands to complex data types (e.g., concomitant medications, adverse events) and implements the reconciliation feedback loop. Here, we add agents that compare EDC query responses with the source EHR, flagging discrepancies for human review in a dedicated dashboard. Phase 3 scales the validated pipeline across multiple study sites and prepares the API-based submission layer to the EDC (e.g., Medidata RAVE, Veeva). The final Phase 4 integrates all components into a single LangGraph or Temporal-based orchestration layer, adds comprehensive monitoring, and completes operational handoff with full audit trails for 21 CFR Part 11 compliance.
Comparison of key operational and financial metrics for manual double-data entry versus a custom AI agentic workflow that automates patient data transfer from EHR to Electronic Data Capture (EDC) systems for clinical trials.
| Metric | Manual Process (Current State) | Custom AI Agentic Workflow |
|---|---|---|
Cycle Time per Patient Record | 45–90 minutes | 3–5 minutes |
Site Coordinator Burden (FTE hours per study) | 15–25 hours per month | 2–4 hours per month |
Data Entry Error Rate | 2–5% (requiring query resolution) | <0.5% (with automated validation) |
Time to Database Lock (for a 200-patient study) | 4–6 weeks post-last visit | 1–2 weeks post-last visit |
Audit Trail & Reconciliation Coverage | Partial, manual logs | Complete, immutable API logs |
Cost of Data Management per Patient | $150–$300 | $40–$80 |
Regulatory Inspection Readiness | Weeks of preparation | Real-time, on-demand reporting |
Scalability for Decentralized Trials | Poor, high marginal cost | High, low marginal cost |
A production-grade automation for transferring patient data from EHRs to Electronic Data Capture (EDC) systems requires a deliberate architecture for governance, control, and safe deployment. This section details the critical oversight mechanisms and phased implementation strategy necessary for a compliant, reliable build.
The governance model for an EHR-to-EDC transfer must enforce data integrity and create a defensible audit trail. This is achieved by embedding control agents that validate every data mapping against the trial's annotated Case Report Form (CRF), perform cross-field logic checks, and cryptographically sign each transfer event. All actions—extractions, transformations, submissions, and exceptions—are logged with full provenance to a system like Datadog or Splunk, creating an immutable record for sponsor audits and regulatory inspection. This control layer turns automation from a black box into a governed business process.
A phased rollout is non-negotiable for risk management. Phase 1 implements read-only validation, running the full extraction and transformation logic against a synthetic or de-identified patient cohort, logging all outputs without submitting to the live EDC (e.g., Medidata Rave, Oracle Clinical). Phase 2 introduces a dual-write mode, where all data is submitted to a sandbox EDC instance while being manually entered into production, enabling parallel validation. Only after achieving >99.5% accuracy across all CRF pages in Phase 2 does Phase 3 commence, activating fully automated production transfers, starting with a single, low-risk study site and expanding conservatively.
Enabling Efficiency, Speed & Accuracy
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Practical questions from clinical research and IT leaders about implementing a custom AI agentic workflow to automate patient data transfer from EHRs to Electronic Data Capture (EDC) systems for clinical trials.
A production workflow uses a multi-stage validation architecture. First, extraction agents apply schema validation and data-type checks against the source EHR's FHIR resources. A dedicated mapping agent then validates each transformed value against the target EDC's CDISC ODM schema or API constraints. Discrepancies are routed to an exception queue for human data manager review. The system logs all transformations with source-to-target lineage, enabling audit and correction. Data quality metrics (completeness, accuracy) are monitored in dashboards to trigger alerts on drift.
About the author
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
How We Work
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
The first call is a practical review of your use case and the right next step.
